CLINICAL_TRIALS trial_result · 2021-02-10

Clinical Trial Update: New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly [Phase 2, Phase 3]

A phase 2/3 study evaluated the humoral immune response to a Tick-borne Encephalitis vaccine in elderly participants and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sormland County Council, Sweden | Conditions: Tick-borne Encephalitis | Phase 2, Phase 3 | Status: COMPLETED